-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on Vistra, Lowers Price Target to $226

Benzinga·10/21/2026 16:55:08
Listen to the news
Morgan Stanley analyst Stephen Byrd maintains Vistra (NYSE:VST) with a Overweight and lowers the price target from $227 to $226.